160 related articles for article (PubMed ID: 27997199)
1. Hyaluronic Acid Coated Albumin Nanoparticles for Targeted Peptide Delivery to the Retina.
Huang D; Chen YS; Rupenthal ID
Mol Pharm; 2017 Feb; 14(2):533-545. PubMed ID: 27997199
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid coated albumin nanoparticles for targeted peptide delivery in the treatment of retinal ischaemia.
Huang D; Chen YS; Green CR; Rupenthal ID
Biomaterials; 2018 Jun; 168():10-23. PubMed ID: 29597134
[TBL] [Abstract][Full Text] [Related]
3. Sustained intravitreal delivery of connexin43 mimetic peptide by poly(D,L-lactide-co-glycolide) acid micro- and nanoparticles--Closing the gap in retinal ischaemia.
Chen YS; Green CR; Wang K; Danesh-Meyer HV; Rupenthal ID
Eur J Pharm Biopharm; 2015 Sep; 95(Pt B):378-86. PubMed ID: 25497487
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal injection of lipoamino acid-modified connexin43 mimetic peptide enhances neuroprotection after retinal ischemia.
Chen YS; Green CR; Teague R; Perrett J; Danesh-Meyer HV; Toth I; Rupenthal ID
Drug Deliv Transl Res; 2015 Oct; 5(5):480-8. PubMed ID: 26238242
[TBL] [Abstract][Full Text] [Related]
5. Hyaluronan-modified core-shell liponanoparticles targeting CD44-positive retinal pigment epithelium cells via intravitreal injection.
Gan L; Wang J; Zhao Y; Chen D; Zhu C; Liu J; Gan Y
Biomaterials; 2013 Aug; 34(24):5978-87. PubMed ID: 23680367
[TBL] [Abstract][Full Text] [Related]
6. Effect of hyaluronic acid-binding to lipoplexes on intravitreal drug delivery for retinal gene therapy.
Martens TF; Peynshaert K; Nascimento TL; Fattal E; Karlstetter M; Langmann T; Picaud S; Demeester J; De Smedt SC; Remaut K; Braeckmans K
Eur J Pharm Sci; 2017 May; 103():27-35. PubMed ID: 28223236
[TBL] [Abstract][Full Text] [Related]
7. Hyaluronic-Coated Albumin Nanoparticles for the Non-Invasive Delivery of Apatinib in Diabetic Retinopathy.
Radwan SE; El-Kamel A; Zaki EI; Burgalassi S; Zucchetti E; El-Moslemany RM
Int J Nanomedicine; 2021; 16():4481-4494. PubMed ID: 34239300
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxicity and vitreous stability of chemically modified connexin43 mimetic peptides for the treatment of optic neuropathy.
Chen YS; Toth I; Danesh-Meyer HV; Green CR; Rupenthal ID
J Pharm Sci; 2013 Jul; 102(7):2322-31. PubMed ID: 23696181
[TBL] [Abstract][Full Text] [Related]
9. Ultrasound-mediated nanoparticle delivery across ex vivo bovine retina after intravitreal injection.
Huang D; Chen YS; Thakur SS; Rupenthal ID
Eur J Pharm Biopharm; 2017 Oct; 119():125-136. PubMed ID: 28602870
[TBL] [Abstract][Full Text] [Related]
10. Coating nanocarriers with hyaluronic acid facilitates intravitreal drug delivery for retinal gene therapy.
Martens TF; Remaut K; Deschout H; Engbersen JF; Hennink WE; van Steenbergen MJ; Demeester J; De Smedt SC; Braeckmans K
J Control Release; 2015 Mar; 202():83-92. PubMed ID: 25634806
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid ion-pairing nanoparticles for targeted tumor therapy.
Li W; Yi X; Liu X; Zhang Z; Fu Y; Gong T
J Control Release; 2016 Mar; 225():170-82. PubMed ID: 26826304
[TBL] [Abstract][Full Text] [Related]
12. HA/HSA co-modified erlotinib-albumin nanoparticles for lung cancer treatment.
Shen Y; Li W
Drug Des Devel Ther; 2018; 12():2285-2292. PubMed ID: 30087553
[TBL] [Abstract][Full Text] [Related]
13. Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells.
Maiolino S; Russo A; Pagliara V; Conte C; Ungaro F; Russo G; Quaglia F
J Nanobiotechnology; 2015 Apr; 13():29. PubMed ID: 25888948
[TBL] [Abstract][Full Text] [Related]
14. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells.
Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN
Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859
[TBL] [Abstract][Full Text] [Related]
15. CD44-Targeted Hyaluronic Acid-Coated Redox-Responsive Hyperbranched Poly(amido amine)/Plasmid DNA Ternary Nanoassemblies for Efficient Gene Delivery.
Gu J; Chen X; Ren X; Zhang X; Fang X; Sha X
Bioconjug Chem; 2016 Jul; 27(7):1723-36. PubMed ID: 27311558
[TBL] [Abstract][Full Text] [Related]
16. Connexin43 Mimetic Peptide Improves Retinal Function and Reduces Inflammation in a Light-Damaged Albino Rat Model.
Guo CX; Mat Nor MN; Danesh-Meyer HV; Vessey KA; Fletcher EL; O'Carroll SJ; Acosta ML; Green CR
Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):3961-73. PubMed ID: 27490318
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid-coated chitosan nanoparticles induce ROS-mediated tumor cell apoptosis and enhance antitumor efficiency by targeted drug delivery via CD44.
Wang T; Hou J; Su C; Zhao L; Shi Y
J Nanobiotechnology; 2017 Jan; 15(1):7. PubMed ID: 28068992
[TBL] [Abstract][Full Text] [Related]
18. Stealth CD44-targeted hyaluronic acid supramolecular nanoassemblies for doxorubicin delivery: probing the effect of uncovalent pegylation degree on cellular uptake and blood long circulation.
Han X; Li Z; Sun J; Luo C; Li L; Liu Y; Du Y; Qiu S; Ai X; Wu C; Lian H; He Z
J Control Release; 2015 Jan; 197():29-40. PubMed ID: 25449802
[TBL] [Abstract][Full Text] [Related]
19. Connexin43 mimetic peptide reduces vascular leak and retinal ganglion cell death following retinal ischaemia.
Danesh-Meyer HV; Kerr NM; Zhang J; Eady EK; O'Carroll SJ; Nicholson LF; Johnson CS; Green CR
Brain; 2012 Feb; 135(Pt 2):506-20. PubMed ID: 22345088
[TBL] [Abstract][Full Text] [Related]
20. Sorbitan ester nanoparticles (SENS) as a novel topical ocular drug delivery system: Design, optimization, and in vitro/ex vivo evaluation.
Alvarez-Trabado J; López-García A; Martín-Pastor M; Diebold Y; Sanchez A
Int J Pharm; 2018 Jul; 546(1-2):20-30. PubMed ID: 29753904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
